Navigation Links
Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA
Date:12/14/2009

MOUNTAIN VIEW, Calif., Dec. 14 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced that it has submitted its New Drug Application (NDA) for Staccato® loxapine (AZ-004) to the US Food and Drug Administration (FDA). AZ-004 is an inhalation product candidate being developed for the rapid treatment of agitation in patients with schizophrenia or bipolar disorder. The IND for Staccato loxapine was filed with the FDA in August 2005.

"AZ-004 has delivered a predictable and consistent safety and efficacy profile in treating patients with agitation," said James V. Cassella, PhD, Senior Vice President, Research and Development at Alexza. "We believe that AZ-004, if approved, has the potential to change the treatment practices for acute agitation, as the only product able to meet both the patients' desire for quickly and comfortably gaining control, and the clinicians' goal of rapidly and reliably calming an agitated patient."

"The data we have seen from the Staccato loxapine trials are compelling," said Michael Lesem, MD, Executive Medical Director, Claghorn-Lesem Research Clinic, Houston, TX. "The product exhibits a rapid and predictable reduction in agitation, and appears to have a favorable safety profile in these patient populations."

"We once again exceeded our corporate goal timeline with the AZ-004 NDA submission," said Thomas B. King, President and CEO of Alexza. "The continued concentrated effort of the entire Alexza team throughout 2009 has been nothing short of remarkable and allowed us to complete this landmark milestone for the company. We eagerly look forward to 2010, as we work toward the approval of this product candidate."

"When Alexza was founded, I had the vision that its proprietary technology had the potential to improve the therapeu
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference
2. Alexza to Announce 2009 Third Quarter Financial Results and Update Its AZ-004 NDA Status on Monday, November 9, 2009
3. Alexza Pharmaceuticals to Present at the Fourth Annual JMP Securities Healthcare Focus Conference
4. Alexza Announces Preliminary Results from its AZ-104 (Staccato(R) Loxapine) Phase 2b Trial in Patients with Migraine Headache
5. Alexza Reports 2009 First Quarter Financial Results and Updates Clinical Pipeline Status
6. Endo Pharmaceuticals and Alexza Pharmaceuticals Conclude Research Collaboration
7. Alexza Initiates AZ-104 (Staccato(R) Loxapine) Phase 2b Clinical Trial in Patients With Migraine Headaches
8. Alexzas AZ-004 (Staccato(R) Loxapine) Meets Primary Endpoint of Treating Acute Agitation in Patients with Bipolar Disorder in Phase 3 Trial
9. Alexzas AZ-004 (Staccato(R) Loxapine) Phase 3 Trial Meets Primary Endpoint of Treating Acute Agitation in Schizophrenic Patients
10. Alexza Reports 2008 Second Quarter Financial Results and Updates Development of Product Candidates
11. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... WORTH, Fla. , Aug. 20, 2014  Glades Drugs, ... , is proud to announce its expansion into a ... , which will feature an 8,000-square-foot office space and state ... currently accepting applications for 100 open positions for the new ... at 4560 Lantana Road will serve as the chain,s corporate ...
(Date:8/20/2014)... , Aug. 20, 2014   Easy Breathe , the ... that its " Easy Blog " - has received more than ...   "We are thrilled that so many people are ... , CEO of Easy Breathe. "We,re committed to making sleep apnea ... Blog to stay informed about sleep apnea news , ...
(Date:8/20/2014)... YORK, Aug 20, 2014 Reportlinker.com announces ... in its catalogue: Global Patient Scales ... This report analyzes the worldwide markets for ... Product Segments: Floor Scales, Infant & Baby Scales, ... provides separate comprehensive analytics for the US, Canada, ...
Breaking Medicine Technology:Glades Drugs Moves to New Corporate Headquarters, 100 Open Positions 2Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 2Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 3Easy Breathe Blog Emerges as the Go-To Resource for Sleep Apnea Sufferers 4Global Patient Scales Industry 2Global Patient Scales Industry 3Global Patient Scales Industry 4Global Patient Scales Industry 5Global Patient Scales Industry 6Global Patient Scales Industry 7Global Patient Scales Industry 8Global Patient Scales Industry 9Global Patient Scales Industry 10Global Patient Scales Industry 11Global Patient Scales Industry 12Global Patient Scales Industry 13Global Patient Scales Industry 14Global Patient Scales Industry 15Global Patient Scales Industry 16Global Patient Scales Industry 17Global Patient Scales Industry 18Global Patient Scales Industry 19
... , , , OSAKA, Japan, ... announced today positive results from PEARL 2 - a ... In this trial, both lurasidone 40 and 120 mg/day were significantly more ... an overall discontinuation rate that was similar to placebo. , , ...
... , , , ... CXM ) today announced that all patients enrolled in the Company,s ... and that it plans to provide detailed safety and efficacy data ... http://www.newscom.com/cgi-bin/prnh/20051018/CARDIUMLOGO ) , , The Phase 2b MATRIX ...
Cached Medicine Technology:Lurasidone Demonstrated Efficacy in Treating Patients With Schizophrenia in Pivotal Phase 3 Study 2Lurasidone Demonstrated Efficacy in Treating Patients With Schizophrenia in Pivotal Phase 3 Study 3Lurasidone Demonstrated Efficacy in Treating Patients With Schizophrenia in Pivotal Phase 3 Study 4Lurasidone Demonstrated Efficacy in Treating Patients With Schizophrenia in Pivotal Phase 3 Study 5Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 2Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 3Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 4Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 5Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 6Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 7Cardium Completes Initial Patient Evaluation Period for MATRIX Phase 2b Excellarate Clinical Study 8
(Date:8/20/2014)... The report “Automotive Airbag and Seat ... Analysis: by Geography - Trends and Forecasts 2014 ... automotive airbag and seatbelt market in terms of ... opportunities in the coming years as well as ... growth indicators, challenges, legislation trends, market dynamics, competitive ...
(Date:8/20/2014)... Pass, OR (PRWEB) August 20, 2014 ... parents are urged to become educated about eye health ... eye examined. One frequently overlooked eye condition that must ... the Sharon Kleyne Hour Power of Water radio show, ... young children increasing exponentially, childhood dry eye is becoming ...
(Date:8/20/2014)... August 20, 2014 B. E. Smith, ... healthcare providers, has been retained to lead a national ... Health Care System in Hermiston, Ore. The top ... E. Smith has recently placed more than 900 healthcare ... System is a progressive, not-for-profit healthcare organization serving a ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 Hope For ... Give Hope® Celebration to be hosted in Washington, DC ... Navy Club. This signature event honors the courage of ... of the fallen. Proceeds from the Got Heart, Give ... national nonprofit dedicated to restoring a sense of self, ...
(Date:8/20/2014)... Inc. Magazine recently named Etransmedia ... annual Inc. 500|5000, an exclusive ranking of the ... most comprehensive look at the most important segment ... Yelp, Pandora, Timberland, Dell, Domino’s Pizza, LinkedIn, Zillow ... as members of the Inc. 500|5000. , “We ...
Breaking Medicine News(10 mins):Health News:Automotive Airbag Market Worth $23.6 Billion and Automotive Seat Belt Market Worth $9.0 Billion by 2019 – New Report by MarketsandMarkets 2Health News:Automotive Airbag Market Worth $23.6 Billion and Automotive Seat Belt Market Worth $9.0 Billion by 2019 – New Report by MarketsandMarkets 3Health News:Automotive Airbag Market Worth $23.6 Billion and Automotive Seat Belt Market Worth $9.0 Billion by 2019 – New Report by MarketsandMarkets 4Health News:August is Children’s Eye Health Month, Exams Must Check for Pediatric Dry Eye 2Health News:August is Children’s Eye Health Month, Exams Must Check for Pediatric Dry Eye 3Health News:Good Shepherd Health Care System Retains B. E. Smith to Recruit New COO 2Health News:Good Shepherd Health Care System Retains B. E. Smith to Recruit New COO 3Health News:Hope For The Warriors Announces Got Heart, Give Hope Celebration in Washington, DC 2Health News:Etransmedia Makes Exclusive List for the Eighth Consecutive Year in Inc. Magazine 2Health News:Etransmedia Makes Exclusive List for the Eighth Consecutive Year in Inc. Magazine 3
... U.S. Food and Drug Administration (FDA) today cleared for U.S. ... save the arms and legs of soldiers critically injured// in ... emergency situations. ,FDA reviewed the Temporary Limb ... less than one week because of the critical need for ...
... New research suggests that strep infections in children may ... psychiatric disorders. ,In an eight-month study of ... of Florida researchers found that shortly after the number ... a corresponding rise in involuntary movements and disruptive behaviors ...
... of nine and 12 are most likely to gain weight, a ... more than 2,300 girls aged nine and 10 and followed them ... weight, blood pressure and cholesterol every year through age 18, then ... 23. Roughly half of the girls were white and half were ...
... doctors of Indian origin in Britain - many of them ... - after they lost a case Friday against changes in ... in the country's National Health Service (NHS). ,Many ... of returning home, while others waiting to find employment find ...
... link between zinc supplementation and reduced atherosclerosis in rabbit ... to their hypothesis that the effect may be due ... ,Researchers from the National University of Singapore reported ... year that supplementation of a high cholesterol diet with ...
... In the recent years, scientists discovered a family of ... organisms// as diverse as yeast, worms, and flies. ... Wistar Institute points to another strategy for activating sirtuins ... able to control age-associated metabolic disorders, including obesity and ...
Cached Medicine News:Health News:FDA Clears Critical Limb-Saving Vascular Device 2Health News:Strep, Psychiatric Symptoms Possibly Linked in Some Children 2Health News:Strep, Psychiatric Symptoms Possibly Linked in Some Children 3Health News:Adolescent Girls More Likely to Gain Weight: Study 2Health News:Indian Doctors in Britain Lose Legal Battle 2Health News:Indian Doctors in Britain Lose Legal Battle 3Health News:Indian Doctors in Britain Lose Legal Battle 4Health News:More Support for Zinc-antiatherogenic Link 2Health News:More Support for Zinc-antiatherogenic Link 3Health News:Anti-Aging Powers of Enzyme Sirtuins 2
... of the vocal cords in even the most ... like a standard laryngoscope, Viewmax® does not require ... its ability to allow intubation whether you are ... airway. It has a patented lens system that ...
... Snap-Light™ laryngoscope blades are designed with the ... optic bundle can be removed to simplify ... reach areas. Our unique snap-on mechanism eliminates ... focused blades are interchangeable with other green ...
... Greenspec Laryngoscopes are a high quality fiberoptic ... bringing greater standardization to fiberoptic laryngoscopes. The ... and indicates it's ability to interconnect with ... light offers a cool, bright and focused ...
... steel. Lamp supplied with blade. Oxygen ... operate on any standard/conventional handle allowing ... illumination without the potential confusion from ... blades offer an easy and cost ...
Medicine Products: